edgen-logoBeta

Chat with Ed

Brief

Invest
Plan
Goal
Others

Desk

News

Discover
Missions
Follow our


EN
Back


healthcare: biotechNews

MarketsEconomyTech & AIEnergyHealthcareHK & ChinaFinance

Pharma

Biotech

Health Services

Medical Devices

MaxCyte shares slip 5.7% on Genentech cell therapy license deal

MaxCyte shares slip 5.7% on Genentech cell therapy license deal

Jul 21 2026, 12:42
Immix Biopharma drops 13% after fugitive CMO arrest sparks probe

Immix Biopharma drops 13% after fugitive CMO arrest sparks probe

Jul 20 2026, 16:42
Viking Therapeutics starts phase 1 trial for next-gen obesity drug beyond GLP-1

Viking Therapeutics starts phase 1 trial for next-gen obesity drug beyond GLP-1

Jul 18 2026, 20:38
4DMT's gene therapy cuts wet AMD injections 78% in 2-year trial

4DMT's gene therapy cuts wet AMD injections 78% in 2-year trial

Jul 18 2026, 19:36
AI cancer diagnosis hits 92% accuracy in gallbladder cancer breakthrough

AI cancer diagnosis hits 92% accuracy in gallbladder cancer breakthrough

Jul 18 2026, 09:08
uniQure sharpens gene therapy focus as AMT-130 targets 2026 FDA filing

uniQure sharpens gene therapy focus as AMT-130 targets 2026 FDA filing

Jul 17 2026, 20:10
REGENXBIO raises $100M in stock offering as shares fall 15%

REGENXBIO raises $100M in stock offering as shares fall 15%

Jul 17 2026, 11:39
Jasper Therapeutics merges with Kira in $132M biotech deal

Jasper Therapeutics merges with Kira in $132M biotech deal

Jul 16 2026, 21:30
Silence Therapeutics surges 107% as divesiran data looms in 2026

Silence Therapeutics surges 107% as divesiran data looms in 2026

Jul 16 2026, 18:32
Biogen's diranersen slows Alzheimer's decline 26% in phase 2 trial

Biogen's diranersen slows Alzheimer's decline 26% in phase 2 trial

Jul 14 2026, 13:31
Avere launches via NextCure reverse merger with $320M PIPE

Avere launches via NextCure reverse merger with $320M PIPE

Jul 14 2026, 11:37
Spero Therapeutics secures $1.1B licensing deal for anti-CD40L antibody

Spero Therapeutics secures $1.1B licensing deal for anti-CD40L antibody

Jul 14 2026, 10:42
Agenus shares surge 100% on $340M private placement for colon cancer trial

Agenus shares surge 100% on $340M private placement for colon cancer trial

Jul 13 2026, 17:35
Q32 Bio surges 60% as bempikibart hits alopecia endpoint in Phase 2

Q32 Bio surges 60% as bempikibart hits alopecia endpoint in Phase 2

Jul 13 2026, 17:33
China drug out-licensing hits $110B record in H1 2026

China drug out-licensing hits $110B record in H1 2026

Jul 13 2026, 10:03
Antengene receives $60M upfront from UCB in ATG-201 licensing deal

Antengene receives $60M upfront from UCB in ATG-201 licensing deal

Jul 13 2026, 04:46
AI drug discovery faces a $400 billion question on Wall Street

AI drug discovery faces a $400 billion question on Wall Street

Jul 13 2026, 03:42
Vivani Medical's GLP-1 implant targets 40M patients struggling with adherence

Vivani Medical's GLP-1 implant targets 40M patients struggling with adherence

Jul 11 2026, 12:30
Apnimed files IPO for sleep apnea pill after positive Phase 3 trial

Apnimed files IPO for sleep apnea pill after positive Phase 3 trial

Jul 10 2026, 23:27
Cytokinetics launches Myqorzo as 275 prescribers fuel early uptake

Cytokinetics launches Myqorzo as 275 prescribers fuel early uptake

Jul 10 2026, 19:35

Feature
Financial Fitness
Pricing
Guides
What is a Money Person
What is Financial Fitness
RSU vested money tool
Are you behind on retirement savings
Check-up
Finance Reality Check
Money Personality
Will You Be a Billionaire
Terms of UsePrivacy Policy
© 2026 Finture Development Limited (Ed:Wealth). All rights reserved.